CDC-RFA-GH21-2179.pdf

Centers for Disease Control and Prevention

Center for Global Health

Partnering with Regional Institutes to Strengthen Essential Public Health Functions in Vietnam

CDC-RFA-GH21-2179

08/13/2021

Table of Contents A. Funding Opportunity Description

B. Award Information

C. Eligibility Information

D. Application and Submission Information

E. Review and Selection Process

F. Award Administration Information

G. Agency Contacts

H. Other Information

I. Glossary

Part I. Overview Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Subscribe" button link to ensure they receive notifications of any changes to CDC-RFA- GH21-2179. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry (ATSDR) B. Notice of Funding Opportunity (NOFO) Title:

Partnering with Regional Institutes to Strengthen Essential Public Health Functions in Vietnam C. Announcement Type: New - Type 1:

This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52- 2.pdf. Guidance on how CDC interprets the definition of research in the context of public health can be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr- 46/index.html (See section 45 CFR 46.102(d)).

New Type 1

D. Agency Notice of Funding Opportunity Number:

CDC-RFA-GH21-2179

E. Assistance Listings Number:

93.318 F. Dates:

1. Due Date for Letter of Intent (LOI):

N/A https://www.grants.gov/ https://www.grants.gov/ https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html

2. Due Date for Applications:

08/13/2021 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov.

3. Due Date for Informational Conference Call:

N/A

G. Executive Summary:

1. Summary Paragraph The U.S. Centers for Disease Control and Prevention (CDC) has partnered with the Government of Vietnam (GVN) since 1998 to improve and protect the health of the Vietnamese people. As part of its public health strategy, the GVN is working fast-paced toward compliance with the International Health Regulations of 2005 (IHR) (2005). Vietnam conducted a Joint External Evaluation (JEE) in 2016 and identified numerous recommendations for improving capacity in 19 technical areas. Since then, CDC has worked closely with GVN to strengthen the host government capacity in several Global Health Security Agenda (GHSA) Action Packages. The purpose of this NOFO is to strengthen capabilities of the four Public Health Institutes under the Ministry of Health in the Socialist Republic of Vietnam to execute World Health Organization (WHO) essential public health functions. Key components include support for GHSA focus areas, including preventing avoidable epidemics, early detection of threats, and rapid and effective response; and support for additional programs performing cross-cutting public health functions at the regional level. This NOFO has a required component funding structure. Please refer to Funding Strategy section.

a. Eligible Applicants:

Single

b. Funding Instrument Type:

CA (Cooperative Agreement)

c. Approximate Number of Awards

d. Total Period of Performance Funding:

$ 700,000,000

e. Average One Year Award Amount:

$ 5,000,000

f. Total Period of Performance Length:

g. Estimated Award Date:

September 30, 2021

h. Cost Sharing and / or Matching Requirements:

No Part II. Full Text A. Funding Opportunity Description

1. Background

a. Overview https://www.grants.gov/

The U.S Government’s (USG) Global Health Security (GHS) envisions a world safe and secure from global health threat posed by infectious diseases, where it is possible to prevent or mitigate the impact of naturally occurring outbreaks and intentional or accidental releases of dangerous pathogens, rapidly detect and transparently report outbreaks when they occur, and employ an interconnected global network that can respond effectively to limit the spread of infectious disease outbreaks in humans and animals, mitigate human suffering and the loss of human life, and reduce economic impact.

In partnership with the Government of Vietnam, CDC seeks to accelerate progress toward a world safe and secure from infectious disease threats and to promote global health security as an international security priority. This funding opportunity seeks to build upon previously funded GHS activities by CDC to collaboratively work with the Government of Vietnam to develop a roadmap to IHR compliance and achievement of the GHS targets and action packages. Activities supported through this NOFO will assess and assure the health of the people of Vietnam through the provision of essential public health services and strengthen capabilities for multi-disease, multi-condition surveillance, response, prevention, and control.

CDC has been a leader in improving global health security (GHS) for many decades and plays an important role in the Global Health Security Agenda. CDC’s strategy is rooted in science and based on three concepts long embedded in the agency’s mission to protect public health worldwide: 1) Prevent, 2) Detect, 3) Respond (http://www.cdc.gov/globalhealth/security/cdc.htm).

The Department of Health and Human Services’ (HHS) Global Health Strategy articulates three strategic goals that support HHS’ global health vision of a healthier, safer world: 1)protect and promote the health and well-being of Americans through global health action; 2) provide leadership and technical expertise in science, policy, programs and practice to improve global health; and 3) advance United States interests in international diplomacy, development, and security through global health action. http://www.globalhealth.gov/global-programs-and-initiatives/global-health-strategy/

In addition to Core Global Health Security Priorities (Component 1), this NOFO will support additional activities when a disease outbreak or other public health emergency reaches a scale that requires a moderate (Component 2, Rapid Response to Small Scale Infectious Disease Outbreaks or Other Public Health Emergencies) or substantial response (Component 3, Rapid Response to Large-Scale Infectious Disease Outbreaks or other Public Health Emergencies).

Finally, this NOFO supports activities to combat COVID-19 and other emerging infectious disease threats (Component 4, Emerging Infectious Disease Threats [EIDT]). Applicants must apply for all four components.

b. Statutory Authorities This work is authorized under the Section 307 [42 USC 242l] of the Public Health Service Act and Section 301(a) [42 USC 241(a)] of the Public Health Service Act.

c. Healthy People 2030 This project supports the following Healthy People 2030 topic areas:

Global Health http://www.cdc.gov/globalhealth/security/cdc.htm http://www.globalhealth.gov/global-programs-and-initiatives/global-health-strategy/ http://www.globalhealth.gov/global-programs-and-initiatives/global-health-strategy/ https://health.gov/healthypeople/objectives-and-data/browse-objectives/global-health

Public Health Infrastructure Health Care Access and Quality Infectious Disease Emergency Preparedness

d. Other National Public Health Priorities and Strategies Activities funded through this cooperative agreement must align with the following United States Government (USG) and HHS/CDC strategies and policies:

CDC’s strategy for improving global health security (GHS), based on three concepts embedded in the agency’s mission to protect public health worldwide: 1) Prevent 2) Detect 3) Respond https://www.cdc.gov/globalhealth/security/index.htm

The Department of Health and Human Services’ (HHS) Global Health Strategy https://www.hhs.gov/about/agencies/oga/about-oga/why-hhs-works-globally/hhs-global-strategy/index.html

International Health Regulations (IHR) and supporting policies and frameworks https://www.who.int/topics/international_health_regulations/en/

e. Relevant Work This NOFO will support GHS and its targets, and will facilitate national collaboration toward specific public health protection objectives, including IHR (2005) compliance (http://www.cdc.gov/globalhealth/security/).

This NOFO expands the scope of activities previously awarded under GH16-1718: Partnering with Regional Institutes to Strengthen Essential Public Health Functions in Vietnam.

2. CDC Project Description

a. Approach Bold indicates period of performance outcome.

Component 1: Core Global Health Security Priorities

Strategies Short-Term Outcomes (1-3yrs)

Intermediate Outcomes (3-5 years)

Long-Term Outcomes (5 years or more)

Strategy 1:

Strengthen surveillance capacity for program planning and response.

Strategy 2:

Strengthen laboratory

Improved data quality and timelines of surveillance data

Improved public health workforce capacity to respond to health threats

Increased analysis and usage of surveillance data for program planning and response purposes

Increased data sharing between

Improved capacity for early detection and real-time reporting of public health threats.

Improved ability to rapidly detect and characterize infectious disease threats.

Improved national capacity to rapidly and effectively https://health.gov/healthypeople/objectives-and-data/browse-objectives/public-health-infrastructure https://health.gov/healthypeople/objectives-and-data/browse-objectives/health-care-access-and-quality https://health.gov/healthypeople/objectives-and-data/browse-objectives/infectious-disease https://health.gov/healthypeople/objectives-and-data/browse-objectives/emergency-preparedness https://www.cdc.gov/globalhealth/security/index.htm https://www.hhs.gov/about/agencies/oga/about-oga/why-hhs-works-globally/hhs-global-strategy/index.html https://www.hhs.gov/about/agencies/oga/about-oga/why-hhs-works-globally/hhs-global-strategy/index.html https://www.who.int/topics/international_health_regulations/en/ http://www.cdc.gov/globalhealth/security/

Strategies Short-Term Outcomes (1-3yrs)

Intermediate Outcomes (3-5 years)

Long-Term Outcomes (5 years or more) capacity.

Strategy 3:

Strengthen management of public health emergencies

Strategy 4:

Strengthen public health workforce

Strategy 5:

Strengthen implementation of public health programs

Improved multi-sectoral collaboration among host government departments and stakeholders

Enhanced network operations, molecular characterization, and laboratory training programs.

Improved national and regional EOC by health care workers and rapid response functioning and improved multi-sectoral collaboration during emergencies.

Improved quality and mentorship of trainees;

integration with key public health priorities; and cross-sectoral collaboration.

Strengthened technical capacity different sectors (e.g., animal/human).

Improved diagnostic capacity, sample referral, and biosafety and biosecurity.

Decreased time to detect and respond to public health emergencies.

Improved risk communication

Increase health care worker capacity through regular trainings and exercises.

Enhanced use of outbreak investigation data for evidence-based decision-making.

Strengthened management of training activities to improve public health workforce capacity.

respond to public health threats.

Enhanced sustainable national funding for workforce development.

Development of evidence-based public health programs.

Strategies Short-Term Outcomes (1-3yrs)

Intermediate Outcomes (3-5 years)

Long-Term Outcomes (5 years or more) for surveillance, investigation, and data management.

Strengthened public health service delivery programs.

Increased demand for service delivery programs in community-settings.

Increased communication on safety and effectiveness of public health programs.

Components 2, 3, and 4: Rapid Response to Small Scale and Large Scale Infectious Disease Outbreaks and Other Public Health Emergencies and Emerging Infectious Disease Threats (EIDT) Strategies Short-Term

Outcomes (1-3yrs)

Intermediate Outcomes (3-5 years)

Long-Term Outcomes (5 years or more)

Strategy 1:

Intensify active surveillance, case finding, contact tracing, monitoring and other outbreak response measures at local levels

Strategy 2:

Strengthen capabilities for epidemiologic and laboratory analysis and program evaluation

Strategy 3:

Intensify social mobilization, Improved time to deploy healthcare workers to respond and control the spread of infectious diseases

Strengthened coordination and robust emergency preparedness and response capacities

Improved disease outbreak case management and infection control

Shortened time to detect highly infectious disease

Reduced time to reinvigorated public health activities that have been interrupted or slowed due to outbreak response

Improved access to health services by individuals in outbreak affected areas

Increased capacity of countries for early warning, risk reduction and management of

Sustained improvements in timeliness of achieving outbreak/epidemic/pandemic control

Reduced morbidity and mortality attributed to disease outbreaks or other public health threats

Reduced spread of infectious outbreaks into other countries

Improved preparedness for potential future outbreaks and other highly infectious diseases

Strategies Short-Term Outcomes (1-3yrs)

Intermediate Outcomes (3-5 years)

Long-Term Outcomes (5 years or more) community and professional education and engagement.

Strategy 4:

Improve outbreak case management and infection control

Strategy 5:

Strengthen non-outbreak related public health activities that are impacted by the outbreak

Strategy 6:

Increase security and logistics for local responders

Strategy 7:

Strengthen capabilities for preparedness and response to highly infectious diseases outbreaks through active surveillance and case finding

Reduced transmission of highly infectious diseases in clinical and community settings

Increased awareness, knowledge, and support for local disease outbreak response and prevention efforts at the community level

Rapid identification of and containment of highly infectious disease outbreaks national and global health risks

i. Purpose NOFO purpose is to collaborate and support GVN to achieve compliance with IHR (2005). CDC seeks to support the achievement of GHS targets that focus on improving health globally through collaboration and partnership with the GVN. Its purpose is to improve prevention of avoidable epidemics including naturally occurring outbreaks and intentional/accidental releases of dangerous pathogens, improve ability to rapidly detect threats early, including detecting, characterizing, and reporting emerging public health threats and respond rapidly and effectively to public health threats of international concern.

ii. Outcomes Component 1: Core Global Health Security Priorities

Short-Term Outcomes:

o Improved data quality and timelines of surveillance data o Improved public health workforce capacity to respond to health threats o Improved multi-sectoral collaboration among host government departments and stakeholders o Enhanced network operations, molecular characterization, and laboratory training programs.

o Improved national and regional EOC and rapid response functioning and improved multi-sectoral collaboration during emergencies.

o Improved quality and mentorship of trainees; integration with key public health priorities; and cross-sectoral collaboration.

o Strengthened technical capacity for surveillance, investigation, and data management.

o Strengthened public health service delivery programs.

Intermediate Outcomes:

o Increased analysis and usage of surveillance data for program planning and response purposes o Increased data sharing between different sectors (e.g., animal/human).

o Improved diagnostic capacity, sample referral, and biosafety and biosecurity.

o Decreased time to detect and respond to public health emergencies.

o Improved risk communication; and regular training through exercises.

o Enhanced use of outbreak investigation data for evidence-based decision-making.

o Strengthened management of training activities to improve public health workforce capacity.

o Increased demand for service delivery programs in community-settings.

o Increased communication on safety and effectiveness of public health programs.

Long-Term Outcomes:

o Sustained improvements in timeliness of achieving outbreak/epidemic/pandemic control o Reduced morbidity and mortality attributed to disease outbreaks or other public health threats o Reduced spread of infectious outbreaks into other countries o Improved preparedness for potential future outbreaks and other highly infectious diseases

Components 2, 3, and 4: Rapid Response to Small Scale and Large Scale Infectious Disease Outbreaks or other Public Health Emergencies and Emerging Infectious Disease Threats (EIDT)

Short-Term Outcomes:

o Improved time to deploy healthcare workers to respond and control the spread of infectious diseases o Strengthened coordination and robust emergency preparedness and response capacities o Improved disease outbreak case management and infection control o Shortened time to detect highly infectious disease outbreaks through active surveillance and case finding o Reduced transmission of highly infectious diseases in clinical and community settings o Increased awareness, knowledge, and support for local disease outbreak response and prevention efforts at the community level.

o Rapid identification of and containment of highly infectious disease outbreaks

Intermediate Outcomes:

o Reduced time to reinvigorated public health activities that have been interrupted or slowed due to outbreak response o Improved access health services by individuals in outbreak affected areas o Increased capacity of countries for early warning, risk reduction and management of national and global health risks

Long-Term Outcomes:

o Sustained improvements in timeliness of achieving outbreak/epidemic/pandemic control o Reduced morbidity and mortality attributed to disease outbreaks or other public health threats o Reduced spread of infectious outbreaks into other countries o Improved preparedness for potential future outbreaks and other highly infectious diseases

iii. Strategies and Activities Component 1: Core Global Health Security Priorities

Strategy 1: Strengthen surveillance capacity.

Review surveillance systems and identify gaps for improvement.

Continually evaluate the quality of surveillance data and find ways to improve it.

Develop and implement a monitoring and evaluation framework for surveillance systems.

Promote communication of surveillance data in a regular surveillance bulletin.

Strengthen the implementation of event- and indicator-based surveillance, including reporting tools.

Strengthen surveillance for priority zoonotic diseases.

Enhance health information systems in response to evaluations of surveillance systems.

Enhance use of surveillance data for risk assessment, epidemic intelligence, and resource planning and allocation.

Develop e-learning systems to strengthen use of surveillance data.

Train health workers on the use of data analysis, data visualization, risk assessment, and reporting tools.

Develop an implementation plan for health information systems to include vertical disease programs and to integrate surveillance and laboratory data.

Establish a mechanism for sharing data between human and animal health sectors.

Strategy 2: Strengthen laboratory capacity.

Develop key indicators that allow regular monitoring and evaluation of the laboratory system.

Train laboratory staff on monitoring and evaluation of the laboratory system.

Implement national diagnostic algorithms for priority diseases.

Enhance use of standardized laboratory information management system.

Train laboratory staff and provide mentorship on quality management system and biorisk management.

Conduct drill/exercise on quality management system and bio-risk management.

Develop biosafety and biosecurity training materials Provide technical support in developing/updating legislation, technical guidelines, and strategic plans for laboratory Implement a mechanism for sample referral.

Develop a laboratory rapid response operation manual Develop guidelines for management of a biological specimen repository.

Provide technical support developing regulations and guidelines for management of select agents and toxins.

Strategy 3: Strengthen management of public health emergencies.

Develop and assess emergency response plans.

Perform after action reviews.

Establish mechanisms for rapid personnel deployment.

Continuously improve data monitoring, analysis, and visualization in EOCs.

Perform risk assessment and risk mapping.

Activate the national EOC to respond to public health events.

Ensure that EOC staff are competent in following established plans and procedures.

Exercise the coordination of the national EOC network.

Periodically review/update plans and procedures for Emergency Operations Centers

(EOCs).

Review and harmonize existing response guidelines.

Establish mechanisms and policies for risk communication.

Establish policies for cross-sectoral collaboration during public health emergencies.

Strategy 4: Strengthen the public health workforce.

Integrate rigorous monitoring and evaluation into all aspects of workforce development.

Raise the profile of workforce development activities with key leaders and organizations.

Integrate training with efforts to address key public health problems in Vietnam.

Establish a progressive model of field epidemiology training (short course, followed by intermediate, followed by advanced).

Strengthen the management, operations, and coordination of training activities.

Strengthen the management, operations, and coordination of public health workforce that response to disease outbreaks.

Establish and maintain continuous mentor development.

Engage different sectors (e.g., human/animal health, preventive/curative) of GVN in workforce development.

Incorporate mentor development into the existing GVN system.

Strategy 5: Strengthen implementation of public health programs.

Conduct risk and/or needs assessments to identify gaps in public health service delivery programs.

Clarify the roles of healthcare workers in the public health service delivery program.

Strengthen the linkage between healthcare referral systems.

Develop specific SOPs to strengthen the delivery of public health programs.

Conduct trainings of healthcare workers to increase quality of service delivery programs.

Use of data to strengthen service delivery programs.

Conduct public health evaluations to improve quality of service delivery programs.

Components 2, 3, and 4: Rapid Response to Small Scale and Large Scale Infectious Disease Outbreak or other Public Health Emergencies and Emerging Infectious Disease Threats

(EIDT)

Strategy 1: Intensify active surveillance, case finding, contact tracing, monitoring, and other critical response efforts at local levels

Conduct and improve ongoing active surveillance, with laboratory confirmation to ensure rapid identification of missed, new or newly imported outbreak cases

Strengthen capacity for general surveillance including support for personnel required for surveillance and epidemiology activities.

Strengthen surveillance at entry points (border posts, airports and maritime ports) from countries with ongoing transmission

Strategy 2: Strengthen capabilities for epidemiologic and laboratory analysis and program evaluation

Improve operational and technical analysis, coordination and monitoring of interventions Assess the impact of the epidemic on health care seeking and health care provision

Strategy 3: Intensify social mobilization, community and professional education and engagement, and psychosocial care for infected persons and their families where applicable

Conduct intensified social mobilization and community engagement to enhance awareness and gather community support, acceptance and participation in implementation of containment measures

Provide psychosocial first aid training for community agents and their supervisors so they can provide direct psychosocial support to contact cases and their families.

Develop and conduct communications to contain the outbreaks and enforce the theme of "Staying at Zero Cases."

Develop and disseminate key health risk communication messages

Strategy 4: Improve outbreak case management and infection control

Develop plans for patient management at community and clinical settings.

Improve infection control practices, particularly in facilities that might receive outbreak cases for example, on a border with a country with ongoing transmission

Strategy 5: Strengthen non-outbreak related public health activities that are impacted by the outbreak

Restore priority aspects of the health/public health system such as surveillance and assessment of vaccination coverage for epidemic-prone disease (e.g., measles), that are negatively impacted or stalled due to the outbreak

Strategy 6: Increase security and logistics for local responders

Strengthen field security to ensure operational security, and protect national and international staff involved in the response

Strategy 7: Strengthen capabilities for preparedness and response to highly infectious diseases

Develop/implement partnership mechanisms for a more robust and responsive global health emergency workforce.

Train frontline responders on emerging infectious diseases.

Strengthen critical International Health Regulations (IHR) and health systems capacities in affected region and elsewhere

1. Collaborations

a. With other CDC programs and CDC-funded organizations:

Recipient(s) are required to work with other CDC implementing partners, including non-governmental organizations, universities, Ministry of Health and other host governmental bodies and multi-lateral organizations that receive CDC funds. Recipient(s) should ensure their proposed activities are not duplicating activities already implemented by other CDC-funded organizations.

b. With organizations not funded by CDC:

The recipient(s) will work primarily and directly with partner governments specifically with the Ministries of Health and other government entities who are working towards the objectives of this NOFO. In addition, the recipient(s) will be expected to work with other in-country and global stakeholders, including but not limited to government entities, non-governmental organizations, universities, civil society, the private sector, and other United States Government (USG) agencies.

2. Target Populations The target population for this NOFO include those populations that fall under the following jurisdiction(s): Vietnam

The target populations for this NOFO include, but are not limited to, those individuals infected and affected by infectious diseases, or at risk for becoming infected by an infectious disease. The target population for this NOFO may also include at-risk population for non-communicable diseases and/or other public health emergencies.

The work under this NOFO may also target increased capacity at the national and sub-national level to implement activities in alignment with the objectives of this NOFO.

a. Health Disparities Recipient(s) are expected to use epidemiologic, social determinants, and linked laboratory, epidemiological, and surveillance data to identify communities disproportionately affected by infectious diseases or non-communicable diseases in the target areas to ensure that program activities appropriately cover these populations. Recipient(s) should ensure that supported services are accessible and available to all patients regardless of age, sex, race/ethnicity, sexual orientation, gender identity, or socio-economic status in order to achieve the outcomes of this

NOFO.

iv. Funding Strategy This NOFO is divided into four components. Applicants are required to apply for all components and include a separate budget and work plan for each component. The applicant’s application package should be inclusive of all component work plans and budgets; multiple applications will not be reviewed. Applicants are encouraged to submit component budgets toward the year one award ceiling for each component. However, budget proposals for year one may not exceed the year one award ceiling. Please note these amounts are subject to approval and the availability of funds. The emergency components (Components 2 – 4) follow the same logic model with identical overarching strategies and activities, however, Component 2 should support activities when a disease outbreak or other public health emergency reaches a scale that requires a moderate response, Component 3 should support activities when a disease outbreak or other public health emergency reaches a scale that requires a moderate response and Component 4 should support activities to combat COVID-19 and other emerging infectious disease threats.

Component 1: Core Global Health Security Priorities These GHS activities are intended to be funded on an annual basis. The estimated year one ceiling is $5,000,000. Future years funding level will be dependent on funding availability.

Component 2: Rapid Response to Small Scale infectious disease outbreaks or other Public Health Emergencies This is intended to be approved but unfunded (ABU) as a baseline practice. It would be funded to support additional activities needed within a budget period when a disease outbreak or other public health emergency reaches a scale that requires a moderate response. Estimated year one ceiling is $5,000,000.

Component 3: Rapid Response to Large Scale Infectious Disease Outbreaks or other Public Health Emergencies This is intended to be approved but unfunded (ABU) as a baseline practice. It would be funded to support additional activities needed within a budget period when a disease outbreak or other public health emergency reaches a scale that requires a substantial response. Estimated year one ceiling is $10,000,000.

Component 4: Emerging Infectious Disease Threats (EIDT) This is intended to be an approved but unfunded (ABU) component that will support activities to combat COVID-19 and other emerging infectious disease threats globally, including efforts related to global health security, global disease detection and response, global health protection, global immunization, and global coordination on public health. It would be funded to support additional activities needed within a budget period for COVID-19 and other emerging disease threats. Estimated year one funding amount funding amount is $15,000,000.

Emergency Management and Response The ability to respond rapidly and effectively to public health emergencies is a key component of global health security. International public health emergencies including humanitarian crises are by nature unpredictable, requiring fulfilment of changing and often unpredictable needs that vary widely according to context. Consequently, funding for public health emergencies is also unpredictable and based on external factors. In recent years, there has been a sharp rise in the number of people living in regions of the world affected by public health emergencies, including humanitarian emergencies, which has often led to additional funding resources from the USG to respond to these threats. Given this unpredictability and the resulting need for rapid, flexible, and efficient process to award funding under an emergency situation, recipients that are selected for funding under this NOFO will be eligible to receive additional expedited supplemental funding when a public health emergency occurs to scale up activities included within the scope of work of this NOFO.

Definition of public health emergency:

In order to qualify for supplemental emergency funding, one of the following situations must apply:

1. When the UN or the WHO classifies the emergency as a Level 3 (L3)

2. When the US Congress appropriates funding for an international response related to humanitarian or public health crisis with the words containing “emergency” in the program title. The appropriated funding could be for CDC directly or is transferred to CDC through an Interagency Agreement (IAA) by HHS or another USG entity

3. When the US government (Congress, White House, National Security Council, etc.)

declares a public health emergency as national security priority

4. When the CDC Director activates the Emergency Operation Center (EOC) in response to an international public health threat

5. When the Department of State or US Agency for International Development (USAID) transfer funds to CDC to respond to an international disaster or humanitarian assistance under 2 FAM 060 (International Disaster and Humanitarian Assistance)

If a public health emergency situation meets any one criteria listed above, then selected recipients under this NOFO will be eligible to receive supplemental emergency funding to scale up public health activities included in the scope of work of this NOFO on a single-source basis (i.e. without additional competition) within a 12-month budget period and throughout the 60-month period of performance. There is no limit on the number of emergency supplemental funding that a recipient may receive within a 12-month budget period or the 60-month period of performance under a public health emergency situation. Recipients receiving funds under a public health emergency will be eligible to receive emergency funding without constraint to the period of performance funding ceiling, annual budget period ceiling, or lack of component funding. In addition, applications for funding under a public health emergency will not need a merit review and will only require approval from the CDC Project Officer and Grants Management Officer (GMO) in order to be funded.

All reporting requirements listed under this NOFO still apply to any emergency supplemental funding.

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy The applicant should describe how they plan to measure and collect data on the funded activities and bolded outcomes identified in the logic model. The purpose of collecting and reporting these data is to determine the progress toward achieving the NOFO activities and outcomes. The results will also be used for program planning, development and improvement, accountability and reporting, and for sharing with partners and other stakeholders. CDC will work with the recipient throughout the life of this award to ensure that all activities and expected outcomes are in alignment with current USG and the recipient’s strategies and goals. The recipient should dedicate funds made available under this NOFO for evaluation and performance monitoring within each project. The final funding amount will be agreed upon by both CDC and the recipient; however, it should be expected that approximately 3% (of a given project’s funding) will be dedicated to monitoring, reporting, and evaluation activities. CDC and the recipient will agree upon the specific funding amounts within review of each project’s work plan and budget.

Monitoring CDC expects that the work conducted under this NOFO will be structured as a series of discrete projects oriented at achieving elements of the NOFO’s strategic objectives. CDC and the recipient will jointly develop formal performance measures shortly after award based on activities within each project. For each project, these performance measures must include CDC’s Division of Global Health Protection’s Division-wide Indicators (DWIs), as well as other CDC or recipient’s standard indicators relevant to the intended outcomes of the project. The DWIs include indicators that are required reporting for CDC, such as for OMB, HHS, USG Global Health Security Agenda (GHSA) interagency, and Healthy People. At a minimum, applicants should describe proposed process measures for the strategies and activities in the logic model, and proposed outcome measures for the period of performance outcomes in the logic model.

While recipients will be responsible for reporting on DWIs relevant to proposed strategies and activities, they are not limited to only DWIs listed below. Applicants can, and are encouraged to, propose additional relevant indicators that, combined with relevant DWIs, will be monitored over the life of the NOFO. Recipients will also be encouraged to identify relevant USG GHSA Interagency Metrics, WHO Joint External Evaluation (JEE), and/or Healthy People 2030 standardized metrics and WHO benchmarks.

Technical Area Division of Global Health Protection (DGHP) Division-wide Indicators (DWIs) as of April 2019* WD#1: Number of individuals trained by CDC to prevent, detect and respond to public health threats

WD#2: Number of Field Epidemiology Training Program (FETP) residents trained by CDC that have participated in outbreak investigations and responses WD#3: Number and proportion of subnational jurisdictions per country that have had at least one staff member trained by FETP-Frontline

Workforce Development

(WD)

WD#4: Number of CDC staff ready to provide emergency management and response assistance EMR#1: Number of public health events of international importance monitored and reported

EMR#2: Number of public health events and other global health emergency responses supported by CDC EMR#3: Number of outbreaks investigated and responded to by the country

Emergency Management and Response (EMR)

EMR#4: Number and proportion of countries with an established Public Health Emergency Operations Center (PHEOC) that have used their PHEOC for a real-world response or simulation SS/LS#1: Number and proportion of country-prioritized diseases and pathogens with laboratory testing capacity, surveillance system, and routine reporting to public health authorities

SS#2: Number and proportion of countries with a centralized national database that includes linked suspect case reports and laboratory data from subnational jurisdictions for the country’s priority notifiable diseases/syndromes LS#2: Number and proportion of designated laboratories that have bio-risk management policies, physical security controls and inventories for potential high consequence pathogens and toxins LS#3: Number of new diagnostic tests established in national or regional laboratories with CDC support LS#4: Number of new strains or pathogens detected or discovered with CDC support

Surveillance Systems (SS) and Laboratory Systems (LS)

LS#5: Number and proportion of countries that have developed a national laboratory specimen referral system and transport networks

LS#6: Number and proportion of laboratory facilities, designated in the national action plan for antimicrobial resistance (AMR) or as part of a national surveillance system, that conduct antimicrobial susceptibility testing (AST) and have reported susceptibility data to a designated national body LS #7: Number and proportion of countries that have adopted and implemented a national program of quality management systems (QMS) ID#1: Number of countries with a National Public Health Institute (NPHI) that was strengthened with CDC support

Institutional Development (ID) ID#2: Number of countries whose core public health functions

(laboratory, surveillance, workforce development and emergency management and response) are coordinated by the NPHI

* These indicators are subject to change; the latest iteration of the DGHP DWIs should be incorporated into the recipient’s EPMP.

Performance reports will be based on which NOFO activities and outcomes are identified in the logic model. Performance reports will be submitted to CDC in accordance with the requirements listed under this NOFO and overall performance will be reviewed on regular technical calls as well as through joint strategic review meetings.

Evaluation The potential evaluation questions and/or topics below are examples of what the applicant may be expected to answer through evaluation(s). Applicants should include at least 1, but no more than 3 potential evaluation questions, or evaluation topics if specific questions are unknown. It is acceptable to provide only evaluation questions, only evaluation topics, or a combination of both evaluation questions and topic, as needed. Applicants should consider but are not limited to the following areas when developing evaluation questions and/or topics.

Sample Evaluation Topics:

Program evaluations to measure the differences in outbreak responses, or other public health responses, in a country, before and after public health investments (in terms of days of outbreak start, days to outbreak detection, laboratory confirmation of outbreak, days to control outbreak, etc.).

Extent to which enhancements in public health surveillance in a country improved outbreak response (in terms of outbreak(s) controlled, cases averted, and time lags from specimen detection to collection).

Extent to which enhancements of the public laboratory systems, such as addition of a specific laboratory capacity in a country, improved outbreak response (in terms of outbreaks detected controlled, cases averted, and time lags from specimen collection to detection).

Program evaluations to measure if the coverage and capacity of the specimen referral network increased

Final evaluation questions and data sources will be determined together with CDC within six months after the award and will be included in the submission of the evaluation and performance measurement plan (EPMP). Evaluations are expected to align with national, USG, and agency priorities and programmatic gaps, and maybe be reviewed by global action committees. As such, the evaluation topics listed in this announcement may be amended.

Dissemination of Evaluation and Performance Measures: By the end of the period of performance, evaluation and performance measures will yield findings to demonstrate the value of the NOFO. The findings should be disseminated through the Annual Performance Report (APR) and the recipient is expected to pursue additional dissemination in public domains, including in public health journals, including global health journals, conferences and through informal channels (e.g., website, newsletters) where applicable.

ii. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this NOFO. At a minimum, the plan must describe:

How the applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant)

Plans for updating the Data Management Plan (DMP) as new pertinent information becomes available. If applicable, throughout the lifecycle of the project. Updates to DMP should be provided in annual progress reports. The DMP should provide a description of the data that will be produced using these NOFO funds; access to data;

data standards ensuring released data have documentation describing methods of collection, what the data represent, and data limitations; and archival and long-term data preservation plans. For more information about CDC’s policy on the DMP, see https://www.cdc.gov/grants/additionalrequirements/ar-25.html.

Where the applicant chooses to, or is expected to, take on specific evaluation studies, the applicant should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan, including a DMP, if applicable, within the first 6 months of award, as described in the Reporting Section of this NOFO.

c. Organizational Capacity of Recipients to Implement the Approach https://www.cdc.gov/grants/additionalrequirements/ar-25.html

The applicant should succinctly describe their capacity (skills, expertise, experience) to implement the activities proposed under this NOFO. For components 2, 3, and 4, the applicant should detail their ability to carry out emergency operations/coordination. Applicants are encouraged to describe their experience working with the target population, ability to implement project strategies/activities, and their physical infrastructure as it applies to the NOFO.

The applicant should provide as part of their appendix the following documents:

1. Curricula vitae (CVs)/Resumes for positions related to Principal Investigator, Project Director, Business Official, and other key staff related to program planning and implementation, finance, and monitoring and evaluation.

2. Job descriptions (maximum 1 page per job description) for key positions including:

Principal Investigator, Project Director, Business Official, and other key staff related to program planning and implementation, finance, and monitoring and evaluation.

3. Organizational chart (maximum 1 page)

4. Financial management statement that demonstrates experience in managing USG or CDC funds that are similar in size and scope of this NOFO (maximum 1 page).

The above referenced documents to be submitted in the appendix should demonstrate the organization's capacity to address the requirements of the NOFO. Applicants must title these documents in their appendix as follows: "CVs/Resumes," "Job Descriptions," "Organizational Chart," "Financial Statement" and upload as a pdf at www.grants.gov.

d. Work Plan The applicant’s application package should be inclusive of all component work plans and budgets; multiple applications will not be reviewed. Each component must have a separate work plan and budget.

Applicant must include a work plan that demonstrates how the outcomes, strategies, activities, timelines, and staffing will take place over the course of the award. Applicants must submit a detailed work plan for the first year of the project, and a high-level work plan for subsequent years. An example work plan is shown below Applicants are not required to use this format, as long as the information above is demonstrated.

Period of Performance Outcome:

[from Outcomes section and/or logic model]

Outcome Measure:

[from Evaluation and Performance Measurement section]

Strategies and Activities

Process Measure [from Evaluation and Performance Measurement section]

Responsible Position / Party

Completion Date

1.

2.

3.

4.

5.

6.

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and recipients, site visits, and recipient reporting (including work plans, performance, and financial reporting).

Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking recipient progress in achieving the desired outcomes.

Ensuring the adequacy of recipient systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities deemed necessary to monitor the award:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that recipients are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with recipients on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk recipients.

The recipient(s) will be required to collaborate with CDC in-country offices for technical oversight of project activities to be implemented under this NOFO. In addition to the CDC Project Officer, the recipient will collaborate with in-country or HQ contacts, Subject Matter Experts (SMEs), and technical leads. The Project Officer for this award will provide relevant contacts of CDC staff and coordinate discussions with the award recipients.

B. Award Information

1. Funding Instrument Type:

CA (Cooperative Agreement) CDC's substantial involvement in this program appears in the CDC Program Support to Recipients Section.

2. Award Mechanism:

U2H

3. Fiscal Year:

4. Approximate Total Fiscal Year Funding:

$ 35,000,000

5. Total Period of Performance Funding:

$ 700,000,000 This amount is subject to the availability of funds.

Estimated Total Funding:

$ 875,000,000

6. Total Period of Performance Length:

year(s)

7. Expected Number of Awards:

8. Approximate Average Award:

$ 5,000,000 Per Budget Period

9. Award Ceiling:

$ 0 Per Budget Period

This amount is subject to the availability of funds.

There is no award ceiling for this NOFO.

10. Award Floor:

$ 0 Per Budget Period

11. Estimated Award Date:

September 30, 2021

12. Budget Period Length:

12 month(s)

Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the federal government.